Strongbridge Bio Ord
(SBBP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||
| Net Income | -43,633 | -9,670 | -5,387 |
| Depreciation Amortization | 11 | 9 | 3 |
| Income taxes - deferred | -450 | -480 | -93 |
| Accounts payable and accrued liabilities | 1,737 | 236 | 519 |
| Other Working Capital | 1,783 | 665 | 1,413 |
| Other Operating Activity | 3,192 | -264 | 70 |
| Operating Cash Flow | $-37,360 | $-9,504 | $-3,475 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -25 | -24 | -2 |
| Net Acquisitions | -4,269 | N/A | N/A |
| Investing Cash Flow | $-4,294 | $-24 | $-2 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 77,816 | 10,193 | 14,924 |
| Other Financing Activity | -412 | 0 | 0 |
| Financing Cash Flow | $77,404 | $10,193 | $14,924 |
| Exchange Rate Effect | 241 | 70 | -455 |
| Beginning Cash Position | 15,632 | 14,897 | 3,905 |
| End Cash Position | 51,623 | 15,632 | 14,897 |
| Net Cash Flow | $35,991 | $735 | $10,992 |
| Free Cash Flow | |||
| Operating Cash Flow | -37,360 | -9,504 | -3,475 |
| Capital Expenditure | -25 | -24 | -2 |
| Free Cash Flow | -37,385 | -9,528 | -3,477 |